SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-17-018125
Filing Date
2017-05-03
Accepted
2017-05-03 16:28:02
Documents
80
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q form10q.htm 10-Q 631337
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 11174
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 11372
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 6739
5 EXHIBIT 32.2 ex32_2.htm EX-32.2 6656
  Complete submission text file 0001140361-17-018125.txt   5315750

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rnn-20170331.xml EX-101.INS 1352475
7 XBRL TAXONOMY EXTENSION SCHEMA rnn-20170331.xsd EX-101.SCH 55146
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rnn-20170331_cal.xml EX-101.CAL 45615
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rnn-20170331_def.xml EX-101.DEF 162209
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rnn-20170331_lab.xml EX-101.LAB 369543
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rnn-20170331_pre.xml EX-101.PRE 323040
Mailing Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Filer) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34079 | Film No.: 17809595
SIC: 2834 Pharmaceutical Preparations